1991
DOI: 10.1097/00007890-199111000-00005
|View full text |Cite
|
Sign up to set email alerts
|

The Effect of Antilymphocyte Serum, Fractionated Donor Bone Marrow, and Cyclosporine on Renal Allograft Survival in Mongrel Dogs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

1995
1995
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(7 citation statements)
references
References 0 publications
0
7
0
Order By: Relevance
“…This approach has been successful for feline and human patients for many years. In contrast, canine renal transplant is rarely performed in a clinical setting, primarily because of lack of an effective, safe, and affordable immunosuppressive protocol preventing long term graft rejection in unrelated dogs 1–24 …”
Section: Introductionmentioning
confidence: 99%
“…This approach has been successful for feline and human patients for many years. In contrast, canine renal transplant is rarely performed in a clinical setting, primarily because of lack of an effective, safe, and affordable immunosuppressive protocol preventing long term graft rejection in unrelated dogs 1–24 …”
Section: Introductionmentioning
confidence: 99%
“…[6][7][8][9][10] Anti-thymocyte sera alone extended median survival slightly to 17 to 18 days; 6,11 the combination of ATS and cyclosporine (3.2 to 20 mg/kg/day) increased median survival to 22 to 35 days. 11 Median survival times for the oil-based formulation of cyclosporine alone are reported as 13 days (2.5 mg/kg/day), 12 9 days (5 mg/kg/day), 8 and 8 days (10 mg/kg/day) 9 ; for combinations of cyclosporine (20 mg/kg/day) and prednisone as 44 days; and for azathioprine and prednisone as 26 days. 13 Combining cyclsoporine (12.5 mg/kg/day) and azathioprine extended median survival to 68 days.…”
mentioning
confidence: 99%
“…(193-195) Mechanistic studies performed in these models showed that allograft survival correlated with the presence of donor class II mRNA in the recipient’s thymus (196). Studies in canines by the Monaco group demonstrated that donor bone marrow infusion induced prolonged graft survival in a large animal model(197). When this strategy was applied in a primate model using an anti-CD3 immunotoxin and donor bone marrow, prolonged graft survival was again observed(198).…”
Section: Clinical Approaches To Induction Of “Operational” Tolerance mentioning
confidence: 99%